Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells

被引:184
作者
Fehérvári, Z
Sakaguchi, S
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Sakyo Ku, Kyoto 6068507, Japan
[2] RIKEN, Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Immunopathol Lab, Yokohama, Kanagawa 2300045, Japan
[3] Japan Sci & Technol Agcy, CREST Program, Kawaguchi 3320012, Japan
基金
日本学术振兴会;
关键词
anergy; CD25+CD4+T-R; DC; LPS; regulation;
D O I
10.1093/intimm/dxh178
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Naturally occurring CD4(+)CD25(+) regulatory T (T-R) cells play crucial roles in normal immunohomeostasis. CD4(+)CD25(+) T-R cells exhibit a number of interesting in vitro properties including a 'default state' of profound anergy refractory to conventional T cell stimuli. We investigated the in vitro activation requirements of CD4(+)CD25(+) T-R cells using bone marrow-derived DC, which as professional antigen presenting cells (APC) can support the activation of normal naive T cells. Comparison of different APC types revealed that LPS-matured DC were by far the most effective at breaking CD4(+)CD25(+) T-R cell anergy and triggering proliferation, and importantly their IL-2 production. Examination of Foxp3, a key control gene for CD4(+)CD25(+) T-R cells, showed this to be stably expressed even during active proliferation. Although CD4(+)CD25(+) T-R cell proliferation was equivalent to that of CD25(-) cells their IL-2 production was considerably less. Use of IL-2(-/-) mice demonstrated that the DC stimulatory ability was not dependent on IL-2 production; nor did IL-15 appear crucial but was, at least in part, related to costimulation. DC also blocked normal CD4(+)CD25(+) T-R cell-mediated suppression partially via IL-6 secretion. DC therefore possess novel mechanisms to control the suppressive ability, expansion and/or differentiation of CD4(+)CD25(+) T-R cells in vivo.
引用
收藏
页码:1769 / 1780
页数:12
相关论文
共 36 条
  • [1] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
    Asseman, C
    Mauze, S
    Leach, MW
    Coffman, RL
    Powrie, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 995 - 1003
  • [2] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [3] Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide
    Caramalho, I
    Lopes-Carvalho, T
    Ostler, D
    Zelenay, S
    Haury, M
    Demengeot, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) : 403 - 411
  • [4] Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO
  • [5] 2-X
  • [6] Modulation of tryptophan catabolism by regulatory T cells
    Fallarino, F
    Grohmann, U
    Hwang, KW
    Orabona, C
    Vacca, C
    Bianchi, R
    Belladonna, ML
    Fioretti, MC
    Alegre, ML
    Puccetti, P
    [J]. NATURE IMMUNOLOGY, 2003, 4 (12) : 1206 - 1212
  • [7] Interleukin 15: biology and relevance to human disease
    Fehniger, TA
    Caligiuri, MA
    [J]. BLOOD, 2001, 97 (01) : 14 - 32
  • [8] Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003)
    Fontenot, Jason D.
    Gavin, Marc A.
    Rudensky, Alexander Y.
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (03) : 986 - 992
  • [9] Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo
    Gavin, MA
    Clarke, SR
    Negrou, E
    Gallegos, A
    Rudensky, A
    [J]. NATURE IMMUNOLOGY, 2002, 3 (01) : 33 - 41
  • [10] New embo member's review - Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity
    Granucci, F
    Zanoni, I
    Feau, S
    Ricciardi-Castagnoli, P
    [J]. EMBO JOURNAL, 2003, 22 (11) : 2546 - 2551